Interactive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder
暂无分享,去创建一个
Shailendra K. Saxena | S. Saxena | M. Nair | Z. Saiyed | Sudheesh Pilakka-Kanthikeel | Pichili Vijaya Bhaskar Reddy | Zainulabedin Saiyed | Madhavan P. N. Nair | S. Pilakka-Kanthikeel | P. V. Reddy
[1] Sabita Roy,et al. Morphine Negatively Regulates Interferon-γ Promoter Activity in Activated Murine T Cells through Two Distinct Cyclic AMP-dependent Pathways* , 2003, Journal of Biological Chemistry.
[2] P. Simmonds,et al. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. , 1998, Brain : a journal of neurology.
[3] P. Pitha,et al. Binding of Human Immunodeficiency Virus Type 1 to CD4 and CXCR4 Receptors Differentially Regulates Expression of Inflammatory Genes and Activates the MEK/ERK Signaling Pathway , 1998, Journal of Virology.
[4] C. Hall,et al. Human Immunodeficiency Virus-Related Cognitive Impairment and the Acquired Immunodeficiency Syndrome Dementia Complex , 1992, Seminars in neurology.
[5] P. Peterson,et al. Kappa-opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4(+) lymphocytes. , 2002, Biochemical pharmacology.
[6] P. Lusso. HIV and chemokines: implications for therapy and vaccine. , 2002, Vaccine.
[7] Dana Gabuzda,et al. Regulation of Human Immunodeficiency Virus Type 1 Infectivity by the ERK Mitogen-Activated Protein Kinase Signaling Pathway , 1999, Journal of Virology.
[8] J. Ambati,et al. HIV‐1 Tat and opiate‐induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP‐1 and alternative chemokines , 2006, Glia.
[9] Melina V Jones,et al. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia , 2000, Journal of psychopharmacology.
[10] S. Mahajan,et al. Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor. , 2002, Journal of immunology.
[11] Vanessa Rivera-Amill,et al. Morphine and Rapid Disease Progression in Nonhuman Primate Model of AIDS: Inverse Correlation Between Disease Progression and Virus Evolution , 2010, Journal of Neuroimmune Pharmacology.
[12] A. Bruce-Keller,et al. Morphine and HIV‐Tat increase microglial‐free radical production and oxidative stress: possible role in cytokine regulation , 2009, Journal of neurochemistry.
[13] T. Deuel,et al. Polypeptide growth factors: roles in normal and abnormal cell growth. , 1987, Annual review of cell biology.
[14] H. Enslen,et al. Modulation of HIV‐1 infectivity by MAPK, a virion–associated kinase , 1998, The EMBO journal.
[15] C. Heldin,et al. Structural and functional studies on platelet‐derived growth factor. , 1992, The EMBO journal.
[16] Honghong Yao,et al. Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability. , 2011, Blood.
[17] S. Meddows-Taylor,et al. Reduced expression of interleukin-8 receptors A and B on polymorphonuclear neutrophils from persons with human immunodeficiency virus type 1 disease and pulmonary tuberculosis. , 1998, The Journal of infectious diseases.
[18] H. Gendelman,et al. The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. , 1997, Current Opinion in Neurology.
[19] H. Balfour,et al. Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells , 1994, Journal of Neuroimmunology.
[20] T. Murakami,et al. Roles of chemokines and chemokine receptors in HIV-1 infection. , 2000, International journal of hematology.
[21] Alcino J. Silva,et al. CREB and memory. , 1998, Annual review of neuroscience.
[22] M. Krangel,et al. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. , 1992, Critical reviews in immunology.
[23] A. Fauci,et al. Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis , 2000, Immunological reviews.
[24] E. Benveniste,et al. Immune function of astrocytes , 2001, Glia.
[25] D. Yee,et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. , 2002, Cancer research.
[26] T. Rogers,et al. μ-opioid modulation of HIV-1 coreceptor expressionand HIV-1 replication , 2003 .
[27] L. Montagnier,et al. Apoptosis in AIDS. , 1993, Science.
[28] J. Ambati,et al. CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates , 2006, Journal of Neuroimmunology.
[29] A. Garzino-Demo,et al. Chemokine Receptors and Chemokines in HIV Infection , 1998, Journal of Clinical Immunology.
[30] Stuart A. Lipton,et al. Pathways to neuronal injury and apoptosis in HIV-associated dementia , 2001, Nature.
[31] P. Cheney,et al. Morphine Potentiates Neuropathogenesis of SIV Infection in Rhesus Macaques , 2011, Journal of Neuroimmune Pharmacology.
[32] Michael E. Greenberg,et al. CREB: A mediator of long-term memory from mollusks to mammals , 1994, Cell.
[33] J. Gutkind. The Pathways Connecting G Protein-coupled Receptors to the Nucleus through Divergent Mitogen-activated Protein Kinase Cascades* , 1998, The Journal of Biological Chemistry.
[34] D. Donoghue,et al. Structure and function of platelet-derived growth factor (PDGF) and related proteins. , 1989, Biochimica et biophysica acta.
[35] A. Bruce-Keller,et al. Morphine Exacerbates HIV-1 Tat-Induced Cytokine Production in Astrocytes through Convergent Effects on [Ca2+]i, NF-κB Trafficking and Transcription , 2008, PloS one.
[36] Ulf Eriksson,et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke , 2008, Nature Medicine.
[37] J. Zhang,et al. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro , 2001, Neuroscience.
[38] D. Lysle,et al. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell , 2006, Journal of Neuroimmunology.
[39] C Eisdorfer,et al. Aging and neuro-AIDS conditions and the changing spectrum of HIV-1-associated morbidity and mortality. , 2001, Journal of clinical epidemiology.
[40] N. Haigwood,et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis , 1992, The Journal of experimental medicine.
[41] S. Schwartz,et al. Immunoregulatory effects of morphine on human lymphocytes , 1997, Clinical and diagnostic laboratory immunology.
[42] Jie Chen,et al. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia , 2000, AIDS.
[43] M. Baggiolini,et al. Interleukin‐8, a chemotactic and inflammatory cytokine , 1992, FEBS letters.
[44] K. Marder,et al. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia , 2004, Neurology.
[45] I. Schmidt-Wolf,et al. Morphine Reciprocally Regulates IL-10 and IL-12 Production by Monocyte-Derived Human Dendritic Cells and Enhances T Cell Activation , 2006, Molecular medicine.
[46] Dianne Langford,et al. HIV and antiretroviral therapy in the brain: neuronal injury and repair , 2008, Nature Reviews Neuroscience.
[47] A. Nath,et al. Molecular Basis for Interactions of HIV and Drugs of Abuse , 2002, Journal of acquired immune deficiency syndromes.
[48] M. Dorf,et al. Astrocytes express functional chemokine receptors , 2000, Journal of Neuroimmunology.
[49] A. Nath,et al. Molecular targets of opiate drug abuse in neuro AIDS , 2005, Neurotoxicity Research.
[50] A. Garzino-Demo,et al. Beta-chemokines and protection from HIV type 1 disease. , 1998, AIDS research and human retroviruses.
[51] Atta-ur-rahman,et al. Interleukin-8: An autocrine inflammatory mediator. , 1999, Current pharmaceutical design.
[52] Ravikumar Aalinkeel,et al. Morphine modulates chemokine gene regulation in normal human astrocytes. , 2005, Clinical immunology.
[53] Eric R. Kandel,et al. Cell Adhesion Molecules, CREB, and the Formation of New Synaptic Connections , 1996, Neuron.
[54] R. Savani,et al. Morphine Enhances HIV Infection of Neonatal Macrophages , 2003, Pediatric Research.
[55] Sulie L. Chang,et al. HIV-1 gp120 up-regulation of the mu opioid receptor in TPA-differentiated HL-60 cells. , 2006, International immunopharmacology.
[56] S. Woodman,et al. Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. , 2000, The American journal of pathology.
[57] T. Eisenstein,et al. Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. , 1993, Life sciences.
[58] S. Mahajan,et al. Morphine Regulates Gene Expression of α- and β-Chemokines and Their Receptors on Astroglial Cells Via the Opioid μ Receptor1 , 2002, The Journal of Immunology.
[59] Peter Simmonds,et al. Impact of HIV on regional & cellular organisation of the brain. , 2006, Current HIV research.
[60] C. Payá,et al. Apoptosis in AIDS. , 1997, Advances in pharmacology.
[61] Shuxian Hu,et al. Morphine stimulates CCL2 production by human neurons , 2006, Journal of Neuroinflammation.
[62] David Vlahov,et al. The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[63] M. Buchmeier,et al. Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. , 1998, Journal of immunology.
[64] J. Oppenheim,et al. Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems , 2005, Journal of leukocyte biology.
[65] Cynthia Torres,et al. Modulation by Morphine of Viral Set Point in Rhesus Macaques Infected with Simian Immunodeficiency Virus and Simian-Human Immunodeficiency Virus , 2004, Journal of Virology.
[66] A. Bruce-Keller,et al. CCL5/RANTES Gene Deletion Attenuates Opioid-Induced Increases in Glial CCL2/MCP-1 Immunoreactivity and Activation in HIV-1 Tat-Exposed Mice , 2008, Journal of Neuroimmune Pharmacology.
[67] C. Broder,et al. Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors. , 2001, Cytokine & growth factor reviews.
[68] M. Mayo,et al. Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis. , 2004, The American journal of pathology.
[69] P. Portoghese,et al. Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes. , 2001, Biochemical pharmacology.
[70] V. Asensio,et al. Chemokines and viral diseases of the central nervous system , 2001, Advances in Virus Research.
[71] T. Eisenstein,et al. μ-Opioid Induction of Monocyte Chemoattractant Protein-1, RANTES, and IFN-γ-Inducible Protein-10 Expression in Human Peripheral Blood Mononuclear Cells1 , 2000, The Journal of Immunology.
[72] N. Desai,et al. HIV infection and high-risk behaviors in opioid dependent patients: the Indian context. , 2004, Addictive behaviors.
[73] N. Rothwell,et al. Inflammation in central nervous system injury. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[74] Honghong Yao,et al. Morphine enhances Tat-induced activation in murine microglia , 2009, Journal of NeuroVirology.
[75] J. Clements,et al. Cerebrospinal fluid markers that predict SIV CNS disease , 2004, Journal of Neuroimmunology.
[76] Sabita Roy,et al. Opiate abuse, innate immunity, and bacterial infectious diseases , 2008, Archivum Immunologiae et Therapiae Experimentalis.
[77] R. Vallejo,et al. Opioid Therapy and Immunosuppression: A Review , 2004, American journal of therapeutics.
[78] J. Reynolds,et al. Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells. , 2005, Current HIV research.
[79] E. Major,et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[80] J. Berman,et al. CCL2/Monocyte Chemoattractant Protein-1 Mediates Enhanced Transmigration of Human Immunodeficiency Virus (HIV)-Infected Leukocytes across the Blood–Brain Barrier: A Potential Mechanism of HIV–CNS Invasion and NeuroAIDS , 2006, The Journal of Neuroscience.
[81] Ji Ming Wang,et al. Chemokines as Molecular Targets for Therapeutic Intervention , 1999, Journal of Clinical Immunology.
[82] Frederick A. Schmitt,et al. Acceleration of HIV dementia with methamphetamine and cocaine , 2011, Journal of NeuroVirology.
[83] Nan Zhang,et al. Role of MIP-1β and RANTES in HIV-1 infection of microglia: inhibition of infection and induction by IFNβ , 2000, Journal of Neuroimmunology.
[84] K. Tanaka,et al. Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1 , 1994, Journal of virology.
[85] V. Metelev,et al. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. , 1995, Science.
[86] W. Kelder,et al. β‐Chemokines MCP‐1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus–associated dementia , 1998 .
[87] J. Zamora,et al. CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients: the role of intravenous drug use , 2004, AIDS.
[88] A. Verani,et al. Chemokines as natural HIV antagonists. , 2002, Current molecular medicine.
[89] J. Becker,et al. Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.
[90] Thomas Lehner,et al. The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection. , 2002, Trends in immunology.
[91] T. Eisenstein,et al. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations , 1998, Journal of Neuroimmunology.
[92] A. Nath,et al. Synergistic increases in intracellular Ca2+, and the release of MCP‐1, RANTES, and IL‐6 by astrocytes treated with opiates and HIV‐1 Tat , 2005, Glia.
[93] Shuxian Hu,et al. Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. , 2005, The Journal of infectious diseases.
[94] A. Garzino-Demo,et al. HIV Infection and Pathogenesis: What About Chemokines? , 1999, Journal of Clinical Immunology.
[95] Shaily Malik,et al. A Growth Factor Attenuates HIV-1 Tat and Morphine Induced Damage to Human Neurons: Implication in HIV/AIDS-Drug Abuse Cases , 2011, PloS one.
[96] J. McArthur,et al. HIV-associated neurocognitive disorders: is there a hidden epidemic? , 2010, AIDS.
[97] D. Prough,et al. Interleukin-8, neuroinflammation, and secondary brain injury. , 2000, Critical care medicine.
[98] D. Ostrow,et al. Substance abuse and HIV infection. , 1994, The Psychiatric clinics of North America.
[99] A. Nath,et al. HIV‐1 Tat and morphine have interactive effects on oligodendrocyte survival and morphology , 2009, Glia.
[100] J. Becker,et al. Dementia in AIDS patients , 1993, Neurology.
[101] K. Gupta,et al. Morphine stimulates vascular endothelial growth factor-like signaling in mouse retinal endothelial cells. , 2006, Current neurovascular research.
[102] Yangchao Chen,et al. HIV-1 gp120 primes lymphocytes for opioid-induced, beta-arrestin 2-dependent apoptosis. , 2009, Biochimica et biophysica acta.
[103] S. Barger,et al. Pro‐inflammatory and pro‐oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17β‐estradiol , 2001, Journal of neurochemistry.
[104] R. Donahoe. Multiple ways that drug abuse might influence AIDS progression: clues from a monkey model , 2004, Journal of Neuroimmunology.
[105] H. Balfour,et al. Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection. , 1993, Advances in experimental medicine and biology.
[106] V G Sasseville,et al. Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. , 1996, The American journal of pathology.
[107] Honghong Yao,et al. Morphine Induces Expression of Platelet-Derived Growth Factor in Human Brain Microvascular Endothelial Cells: Implication for Vascular Permeability , 2011, PloS one.